Vidipha Central Pharmaceutical JSC (HOSE:VDP)
50,000
0.00 (0.00%)
At close: Mar 9, 2026
HOSE:VDP Balance Sheet
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2008 | 2007 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '08 Dec 31, 2008 | 2007 |
| Cash & Equivalents | 120,866 | 123,831 | 213,988 | 88,123 | 18,666 | Upgrade
|
| Short-Term Investments | 312,490 | 192,790 | 119,000 | 209,692 | 54,500 | Upgrade
|
| Cash & Short-Term Investments | 433,356 | 316,621 | 332,988 | 297,815 | 73,166 | Upgrade
|
| Cash Growth | 36.87% | -4.92% | 11.81% | 307.04% | 23.57% | Upgrade
|
| Accounts Receivable | 191,988 | 230,480 | 199,693 | 187,387 | 41,717 | Upgrade
|
| Other Receivables | 16,004 | 17,396 | 19,523 | 24,175 | 42.49 | Upgrade
|
| Receivables | 207,992 | 247,876 | 219,216 | 212,187 | 41,760 | Upgrade
|
| Inventory | 264,145 | 346,482 | 296,736 | 341,329 | 33,507 | Upgrade
|
| Prepaid Expenses | 9,887 | 2,416 | 2,019 | 373.94 | 1.42 | Upgrade
|
| Other Current Assets | 822.19 | 8,824 | 24,058 | 63,986 | 3,558 | Upgrade
|
| Total Current Assets | 916,202 | 922,220 | 875,016 | 915,692 | 151,992 | Upgrade
|
| Property, Plant & Equipment | 141,207 | 155,646 | 172,255 | 151,140 | 26,045 | Upgrade
|
| Long-Term Investments | - | - | 5,000 | 5,010 | 4,165 | Upgrade
|
| Other Intangible Assets | 44,372 | 39,179 | 38,926 | 27,822 | 9,236 | Upgrade
|
| Other Long-Term Assets | 490.1 | 8,784 | 1,245 | 204.32 | - | Upgrade
|
| Total Assets | 1,102,270 | 1,125,829 | 1,093,445 | 1,102,194 | 191,437 | Upgrade
|
| Accounts Payable | 98,400 | 50,750 | 36,594 | 71,407 | 13,074 | Upgrade
|
| Accrued Expenses | 26,674 | 45,270 | 40,518 | 53,455 | 1,356 | Upgrade
|
| Short-Term Debt | 198,387 | 258,438 | 273,139 | 336,307 | - | Upgrade
|
| Current Income Taxes Payable | 9,825 | 3,132 | - | 4,736 | 674.91 | Upgrade
|
| Other Current Liabilities | 14,371 | 16,468 | 11,211 | 9,696 | 6,658 | Upgrade
|
| Total Current Liabilities | 347,658 | 374,058 | 361,463 | 475,601 | 21,762 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 292.48 | Upgrade
|
| Total Liabilities | 347,658 | 374,058 | 361,463 | 475,601 | 22,055 | Upgrade
|
| Common Stock | 220,834 | 220,834 | 184,029 | 168,319 | 60,000 | Upgrade
|
| Additional Paid-In Capital | 179,852 | 179,852 | 216,657 | 176,040 | 61,803 | Upgrade
|
| Retained Earnings | 353,926 | 351,085 | 331,296 | 282,235 | 33,916 | Upgrade
|
| Comprehensive Income & Other | - | - | - | - | 13,664 | Upgrade
|
| Shareholders' Equity | 754,612 | 751,771 | 731,982 | 626,593 | 169,382 | Upgrade
|
| Total Liabilities & Equity | 1,102,270 | 1,125,829 | 1,093,445 | 1,102,194 | 191,437 | Upgrade
|
| Total Debt | 198,387 | 258,438 | 273,139 | 336,307 | - | Upgrade
|
| Net Cash (Debt) | 234,969 | 58,183 | 59,848 | -38,491 | 73,166 | Upgrade
|
| Net Cash Growth | 303.84% | -2.78% | - | - | 23.57% | Upgrade
|
| Net Cash Per Share | 10640.06 | - | 2963.04 | -1905.67 | 10160.92 | Upgrade
|
| Filing Date Shares Outstanding | 22.08 | - | 22.08 | 20.2 | 7.2 | Upgrade
|
| Total Common Shares Outstanding | 22.08 | - | 22.08 | 20.2 | 7.2 | Upgrade
|
| Working Capital | 568,544 | 548,162 | 513,553 | 440,091 | 130,230 | Upgrade
|
| Book Value Per Share | 34171.03 | - | 33146.14 | 31022.11 | 23525.33 | Upgrade
|
| Tangible Book Value | 710,241 | 712,592 | 693,056 | 598,772 | 160,147 | Upgrade
|
| Tangible Book Value Per Share | 32161.75 | - | 31383.47 | 29644.68 | 22242.61 | Upgrade
|
| Buildings | 166,402 | 155,975 | 149,233 | 124,746 | 23,592 | Upgrade
|
| Machinery | 262,539 | 258,001 | 251,362 | 217,337 | 42,578 | Upgrade
|
| Construction In Progress | 86.5 | 108.98 | 203.75 | 11,500 | 239.83 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.